CA2002415A1 - Acides alpha-amino-indole-3-acetyque utile contre le diabete, l'obesite et l'atherosclerose - Google Patents
Acides alpha-amino-indole-3-acetyque utile contre le diabete, l'obesite et l'atheroscleroseInfo
- Publication number
- CA2002415A1 CA2002415A1 CA002002415A CA2002415A CA2002415A1 CA 2002415 A1 CA2002415 A1 CA 2002415A1 CA 002002415 A CA002002415 A CA 002002415A CA 2002415 A CA2002415 A CA 2002415A CA 2002415 A1 CA2002415 A1 CA 2002415A1
- Authority
- CA
- Canada
- Prior art keywords
- trifluoromethyl
- alpha
- methyl
- acetic acid
- benzylamino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27055488A | 1988-11-14 | 1988-11-14 | |
US07/270,554 | 1988-11-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2002415A1 true CA2002415A1 (fr) | 1990-05-14 |
Family
ID=23031777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002002415A Abandoned CA2002415A1 (fr) | 1988-11-14 | 1989-11-07 | Acides alpha-amino-indole-3-acetyque utile contre le diabete, l'obesite et l'atherosclerose |
Country Status (6)
Country | Link |
---|---|
JP (1) | JPH04501722A (fr) |
KR (1) | KR920701152A (fr) |
AU (1) | AU4649189A (fr) |
CA (1) | CA2002415A1 (fr) |
IL (1) | IL92294A0 (fr) |
WO (1) | WO1990005721A1 (fr) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2110574A1 (fr) * | 1991-06-21 | 1993-01-07 | Lawrence I. Kruse | Analogues de tryptamine, leur synthese et leur utilisation comme agonistes des recepteurs pseudo-5-ht1 ou 5-ht2 |
US5158969A (en) * | 1991-08-21 | 1992-10-27 | Neurosearch A/S | Indole derivatives as potassium channel blockers |
GB9523999D0 (en) | 1995-11-23 | 1996-01-24 | Lilly Co Eli | Indolyl neuropeptide y receptor antagonists |
US5849764A (en) * | 1995-12-14 | 1998-12-15 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US5780437A (en) * | 1995-12-14 | 1998-07-14 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US6200957B1 (en) | 1995-12-14 | 2001-03-13 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US5756507A (en) * | 1995-12-14 | 1998-05-26 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US6197975B1 (en) | 1995-12-14 | 2001-03-06 | Merck & Co. , Inc. | Antagonists of gonadotropin releasing hormone |
ATE319440T1 (de) * | 1996-12-23 | 2006-03-15 | Merck & Co Inc | Antidiabetische mittel |
US6156767A (en) * | 1997-06-05 | 2000-12-05 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US5985901A (en) * | 1997-06-05 | 1999-11-16 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US6156772A (en) * | 1997-06-05 | 2000-12-05 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US6004984A (en) * | 1997-06-05 | 1999-12-21 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US5981550A (en) * | 1997-06-05 | 1999-11-09 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US6159975A (en) * | 1998-02-11 | 2000-12-12 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US6025366A (en) * | 1998-04-02 | 2000-02-15 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US6110931A (en) * | 1998-04-02 | 2000-08-29 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US6077847A (en) * | 1998-04-02 | 2000-06-20 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US6228867B1 (en) | 1998-04-02 | 2001-05-08 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US5985892A (en) * | 1998-04-02 | 1999-11-16 | Merck & Co., Ltd. | Antagonists of gonadotropin releasing hormone |
US5998432A (en) * | 1998-04-02 | 1999-12-07 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
AU3395000A (en) | 1999-03-10 | 2000-09-28 | Merck & Co., Inc. | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
JP2003526618A (ja) | 1999-03-10 | 2003-09-09 | メルク エンド カムパニー インコーポレーテッド | 性腺刺激ホルモン放出ホルモン拮抗薬としての6−アザインドール化合物 |
EP1171135A4 (fr) | 1999-03-10 | 2002-05-15 | Merck & Co Inc | Composes 6-azaindole utilises comme antagonistes d'une hormone liberant la gonadotropine |
IL130169A (en) * | 1999-05-27 | 2006-08-20 | Neurim Pharma 1991 | Indole derivatives, and pharmaceutical preparations, skin protection preparations, and cosmetics containing them |
PE20010580A1 (es) * | 1999-09-03 | 2001-05-25 | Takeda Chemical Industries Ltd | Composicion farmaceutica para tratar la diabetes |
AU2001277056B2 (en) | 2000-07-25 | 2005-09-29 | Merck & Co., Inc. | N-substituted indoles useful in the treatment of diabetes |
US6620824B2 (en) | 2001-04-11 | 2003-09-16 | Merck & Co., Inc. | Process for the synthesis of gonadotropin releasing hormone antagonists |
WO2005044261A1 (fr) * | 2003-10-27 | 2005-05-19 | University Of Iowa Research Foundation | Promedicaments analogues de la melatonine |
WO2005065050A2 (fr) * | 2003-12-25 | 2005-07-21 | Asahi Kasei Pharma Corporation | Compose bicyclique |
AU2005300045A1 (en) * | 2004-09-27 | 2006-05-04 | Organix, Inc. | Indole compounds useful as serotonin selective agents |
KR100807718B1 (ko) * | 2006-10-17 | 2008-02-28 | 한국생명공학연구원 | 인돌 유도체를 유효성분으로 함유하는 대사성 질환 예방 및치료용 약학적 조성물 |
DE102008030207A1 (de) | 2008-06-25 | 2009-12-31 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 7-Sulfanylmethyl-, 7-Sulfinylmethyl- und 7-Sulfonylmethyl-Indole und ihre Verwendung |
DE102008030206A1 (de) | 2008-06-25 | 2009-12-31 | Bayer Schering Pharma Aktiengesellschaft | 3-Cyanoalky- und 3-Hydroxyalkyl-Indole und ihre Verwendung |
US8912220B2 (en) | 2009-08-10 | 2014-12-16 | Galenea Pharmaceuticals | Compounds and methods of use thereof |
GB201411239D0 (en) * | 2014-06-25 | 2014-08-06 | Takeda Pharmaceutical | Novel compounds |
CN114601825B (zh) * | 2022-02-18 | 2023-08-04 | 复旦大学附属中山医院 | 一种肠道菌群代谢物吲哚-3-甲醛在防治动脉粥样硬化中的应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2542869A (en) * | 1948-03-19 | 1951-02-20 | Merck & Co Inc | N-pyridoxyl-amino acids and process of preparing the same |
US3074942A (en) * | 1958-01-13 | 1963-01-22 | Geigy Chem Corp | alpha-substituted glycine derivatives |
NL125657C (fr) * | 1963-11-26 | |||
GB1080470A (en) * | 1963-12-31 | 1967-08-23 | Merck & Co Inc | Indole derivatives |
EP0031653A1 (fr) * | 1979-12-19 | 1981-07-08 | Beecham Group Plc | Alpha-amino-acides N-substitués, procédés pour leur préparation et compositions pharmaceutiques les contenant |
LU85035A1 (fr) * | 1983-10-07 | 1985-06-19 | Midit | Derives d'amides d'acides amines,leurs preparation et utilisation ainsi que les compositions contenant ces derives |
-
1989
- 1989-10-27 AU AU46491/89A patent/AU4649189A/en not_active Abandoned
- 1989-10-27 WO PCT/US1989/004711 patent/WO1990005721A1/fr unknown
- 1989-10-27 KR KR1019900701508A patent/KR920701152A/ko not_active Application Discontinuation
- 1989-10-27 JP JP2500318A patent/JPH04501722A/ja active Pending
- 1989-11-07 CA CA002002415A patent/CA2002415A1/fr not_active Abandoned
- 1989-11-13 IL IL92294A patent/IL92294A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO1990005721A1 (fr) | 1990-05-31 |
IL92294A0 (en) | 1990-07-26 |
JPH04501722A (ja) | 1992-03-26 |
AU4649189A (en) | 1990-06-12 |
KR920701152A (ko) | 1992-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2002415A1 (fr) | Acides alpha-amino-indole-3-acetyque utile contre le diabete, l'obesite et l'atherosclerose | |
US6255306B1 (en) | 4-indole derivatives as serotonin agonists and antagonists | |
AU655456B2 (en) | 5-heteroyl indole derivatives | |
US5245046A (en) | α-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents | |
CA1256437A (fr) | Derives de substitution en 3,5 de 1-(4'-fluorophenyl) -indoles utiles pour le traitement des troubles psychiques | |
EP0687251B1 (fr) | Derives de 1,3-dihydroindol-2-one substitues en 3 par un groupe azote comme agonistes et/ou antagonistes de la vasopressine et/ou de l'ocytocine | |
EP0950047B1 (fr) | Derives d'indolin-2-one, procede pour leur preparation et compositions pharmaceutiques les contenant | |
JP2722279B2 (ja) | アミノメチレンで置換した非芳香族複素環式化合物及びサブスタンスpのアンタゴニストとしての使用 | |
CA2114593C (fr) | Derives de l'indole de l'indazole et du benzisoxazo le, leur procede de preparation et les compositions pharmace utiques qui les contiennent | |
US5834493A (en) | Indole derivatives as 5-HT1A and/or 5-HT2 ligands | |
EP1753725B1 (fr) | Derives de tetrahydroisoquinolilsulfonamides, leur preparation et leur utilisation en therapeutique | |
CA2092404A1 (fr) | Derives indoliques comme agents antiallergenes et antiinflammatoires | |
EP0636609A1 (fr) | Dérivés du 1-benzyl-1,3-dihydro-indol-2-one, leur préparation, les compositions pharmaceutiques en contenant | |
KR20080042098A (ko) | 신규 1-아릴-3-아자바이사이클로[3.1.0]헥산: 제조 방법 및신경 정신 질환 치료를 위한 용도 | |
US5409941A (en) | 5-heteroyl indole derivatives | |
EP0162695B1 (fr) | 1,3,4,5-Tétrahyrobenzo(cd)indoles-4-amines-6-oxygénés | |
JPH07500353A (ja) | 5−ht1アゴニストとしてのインドール誘導体 | |
JP2001522366A (ja) | ドーパミンd▲上3▼受容体のモジュレーターとしての置換テトラヒドロイソキノリン誘導体 | |
IE65619B1 (en) | Use of gamma amino butyric acid autoreceptor antagonists for the manufacture of medicaments | |
WO1996034870A1 (fr) | Derives d'azacycloalcanes, leur preparation et leurs applications en therapeutique | |
EP0375133A1 (fr) | Acides alpha-amino-indole-3-acétiques, utiles comme agents antidiabétiques, antiobésité et antiartériosclérotiques | |
PT90907B (pt) | Processo para a preparacao de novas 4,5,7,8-tetra-hidro-6h-tiazolo {5,4-d} azepinas e de composicoes farmaceuticas que as contem | |
JP2002510676A (ja) | うつ病治療用のn−アリールオキシエチルアミン誘導体 | |
US5089497A (en) | Substituted piperazines as central nervous system agents | |
JP2003055344A (ja) | 3,7−ジ置換インドール誘導体及びそれを含有する医薬組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |